Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy.
anaphylaxis
mosquito allergy
omalizumab
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
received:
06
06
2021
revised:
03
08
2021
accepted:
15
08
2021
entrez:
1
11
2021
pubmed:
2
11
2021
medline:
2
11
2021
Statut:
epublish
Résumé
Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.
Identifiants
pubmed: 34721849
doi: 10.1002/ccr3.4935
pii: CCR34935
pmc: PMC8529882
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e04935Informations de copyright
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The Authors declare no other conflict of interests.
Références
Lancet. 2013 Oct 19;382(9901):1380
pubmed: 24139121
J Allergy Clin Immunol. 2021 Mar;147(3):1004-1010.e2
pubmed: 33220353
Int Arch Allergy Immunol. 2016;170(1):46-56
pubmed: 27355916
N Engl J Med. 1959 Aug 20;261:374-7
pubmed: 14424947
J Allergy Clin Immunol. 2004 Nov;114(5):1189-94
pubmed: 15536430
Allerg Immunol (Paris). 1999 Oct;31(8):285-7
pubmed: 10572584
Ann Allergy Asthma Immunol. 2010 Jun;104(6):537-9
pubmed: 20568389
Allergy. 2018 Jan;73(1):230-238
pubmed: 28662309
Blood. 2003 Aug 15;102(4):1405-13
pubmed: 12702510
Acta Derm Venereol. 2006;86(4):329-31
pubmed: 16874418
Int J Immunopathol Pharmacol. 2016 Dec;29(4):726-728
pubmed: 27679679
J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):687-8
pubmed: 24565720
Int Arch Allergy Immunol. 2018;176(2):101-105
pubmed: 29788016
Allergol Immunopathol (Madr). 1998 Sep-Oct;26(5):251-4
pubmed: 9885733
Clin Exp Allergy. 2019 Jul;49(7):942-952
pubmed: 31002196
Immunity. 2001 Jun;14(6):801-11
pubmed: 11420049
J Allergy Clin Immunol. 2017 Mar;139(3):873-881.e8
pubmed: 27609658
Ann Allergy Asthma Immunol. 1995 Jan;74(1):39-44
pubmed: 7719881
Expert Opin Drug Discov. 2015;10(9):1033-42
pubmed: 25979110
Lancet. 2020 Jun 27;395(10242):1998-2007
pubmed: 32534628
Clin Exp Allergy. 2019 Jul;49(7):1040-1046
pubmed: 31063674
J Eur Acad Dermatol Venereol. 2012 Jul;26(7):919-22
pubmed: 22541046
Ann Allergy Asthma Immunol. 2013 Feb;110(2):65-9
pubmed: 23352522
Ann Allergy Asthma Immunol. 2007 Sep;99(3):273-80
pubmed: 17910332
Int Arch Allergy Immunol. 1997 Dec;114(4):367-72
pubmed: 9414141
Allergy. 2018 Apr;73(4):744-764
pubmed: 28748641
Allergol Select. 2021 Mar 11;5:128-132
pubmed: 33733040
Eur Ann Allergy Clin Immunol. 2004 Apr;36(4):131-8
pubmed: 15180354
Ann Allergy Asthma Immunol. 2019 Dec;123(6):612-613
pubmed: 31568858
J Allergy Clin Immunol. 2007 Jun;119(6):1550-1
pubmed: 17481708
J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2387-2395.e3
pubmed: 30954641
Int Arch Allergy Immunol. 2014;165(4):271-82
pubmed: 25661054
J Investig Allergol Clin Immunol. 2009;19(3):225-9
pubmed: 19610266
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):109-12
pubmed: 24674685
N Engl J Med. 2013 Mar 7;368(10):924-35
pubmed: 23432142
Allergy. 2017 Apr;72(4):519-533
pubmed: 27861988
Allerg Immunol (Paris). 1999 Jun;31(6):175-84
pubmed: 10443298
Front Immunol. 2017 Dec 22;8:1867
pubmed: 29375552
Med Clin (Barc). 1994 Feb 5;102(4):157
pubmed: 7907159
J Allergy Clin Immunol. 2012 Nov;130(5):1123-1129.e2
pubmed: 22800401
Int J Dermatol. 1990 Oct;29(8):600-1
pubmed: 2242953